Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer
Wei Zheng, Tianchuan Zhu, Lantian Tang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung
Tianchuan Zhu, Yuchen Xiao, Zhenxing Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Fusion of Exosomes and Nanotechnology: Cutting-Edge Cancer Theranostics
R. Agnihotram, Rajib Dhar, Debolina Dhar, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 8, pp. 8489-8506
Closed Access | Times Cited: 12
CAR-NK cells in combination therapy against cancer: A potential paradigm
Junping Li, Hong‐Ming Hu, Kai Lian, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27196-e27196
Open Access | Times Cited: 11
CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Inhalable nanomedicine for lung cancer treatment
Shuiying Zhang, Rui Li, Tong Jiang, et al.
Smart Materials in Medicine (2024) Vol. 5, Iss. 2, pp. 261-280
Open Access | Times Cited: 7
Natural killer cell-derived exosome-based cancer therapy: from biological roles to clinical significance and implications
Chaohua Si, Jianen Gao, Xu Ma
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Exosome therapeutics for non-small cell lung cancer tumorigenesis
Niloufar Orooji, Manouchehr Fadaee, Tohid Kazemi, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Targeted exosome-based nanoplatform for new-generation therapeutic strategies
Wenjing Yin, Hongyin Ma, Yang Qu, et al.
Biomedical Materials (2024) Vol. 19, Iss. 3, pp. 032002-032002
Open Access | Times Cited: 6
Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine
Elena Cojocaru, Ovidiu Rusalim Petriș, Cristian Cojocaru
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1059-1059
Open Access | Times Cited: 6
CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy
Jiawen Huang, Qian Yang, Wen Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
CAR-T cell-derived exosomes: a new perspective for cancer therapy
Farnaz Sani, Shabnam Shojaei, Seyed Amirhossein Tabatabaei, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Recent advances to address challenges in extracellular vesicle-based applications for lung cancer
Gaigai Huang, Wenshu Zheng, Yu Zhou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3855-3875
Open Access | Times Cited: 5
Different origin-derived exosomes and their clinical advantages in cancer therapy
Xiaoyan Jin, Jing Zhang, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Natural Products-Based Inhaled Formulations for Treating Pulmonary Diseases
Jiangyan Yong, Hongli Shu, Xiao Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1723-1748
Open Access | Times Cited: 4
Exosomes of immune cell origin and their therapeutic potential for tumors
Hongru Ai, Yitan Zou, Xinya Zheng, et al.
View (2024)
Open Access | Times Cited: 4
Tumor Microenvironment-Derived Exosomes: A Double-Edged Sword for Advanced T Cell-Based Immunotherapy
Ye Lu, Jiarong Zheng, Pei Lin, et al.
ACS Nano (2024)
Closed Access | Times Cited: 4
Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting
Danqing Zhu, Wonjoon Kim, Hyunjin Lee, et al.
Advanced Materials (2025)
Closed Access
Current status and innovative developments of CAR-T-cell therapy for the treatment of breast cancer
Hany E. Marei, Khaled Bedair, Anwarul Hasan, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Network pharmacological mechanism and molecular experimental validation of artemisinin in the treatment of lung adenocarcinoma
Zhimin Lu, Jialu Jiang, Xuming Yao, et al.
Toxicology and Applied Pharmacology (2025) Vol. 495, pp. 117226-117226
Closed Access
The latest applications of exosome-mediated drug delivery in anticancer therapies
Zhiwei Wen, Wei Zhang, Wei Wu
Colloids and Surfaces B Biointerfaces (2025) Vol. 249, pp. 114500-114500
Closed Access
Rab21-Targeted Nano Drug Delivery System-Based FFPG for Efficient Paclitaxel Delivery to Inhibit Lung Cancer Progression
Jing Wang, Xueying Yan, Wenfei Wang, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 94-94
Open Access
Extracellular Vesicle-based Delivery of Paclitaxel to Lung Cancer Cells: Uptake, Anticancer Effects, Autophagy and Mitophagy Pathways
Shabnam Pirnezhad Talatapeh, Jafar Rezaie, Vahid Nejati
Archives of Medical Research (2025) Vol. 56, Iss. 4, pp. 103194-103194
Closed Access
Stabilized Extracellular Vesicle Formulations for Inhalable Dry Powder Development
Evalyne M. Jansen, Luke van der Koog, Robin A.B. Elferink, et al.
Small (2025)
Open Access
Exosomes and solid cancer therapy: where are we now?
Tomáš Zemánek, Ľuboš Danišovič, Andreas Nicodemou
Medical Oncology (2025) Vol. 42, Iss. 3
Open Access
Application of engineered exosomes in tumor therapy
Chunhui Ma, Wei Tang, Jiaye Wang, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 736-747
Closed Access
Page 1 - Next Page

Scroll to top